Trial Profile
Comparative study of efficacy of minodronate, alendronate and risedronate in patients with osteoporosis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Aug 2013
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary) ; Alendronic acid; Risedronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 09 Aug 2013 New trial record